We are live on
!
Find out more
AC
Athos Capital Portfolio holdings
AUM
$324M
1-Year Est. Return
16.62%
This Fund
S&P 500
This Quarter
Est. Return
-1.14%
1 Year Est. Return
+16.62%
3 Year Est. Return
+82.15%
5 Year Est. Return
+203.21%
10 Year Est. Return
–
AUM
$413M
AUM Growth
-$86.4M
(-17%)
Cap. Flow
-$84M
Cap. Flow
% of AUM
-20.33%
Top 10 Holdings %
Top 10 Hldgs %
38.04%
Holding
179
New
18
Increased
5
Reduced
5
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JOBS
51job Inc
JOBS
|
+$21.4M |
| 2 |
JOYY
JOYY Inc
JOYY
|
+$9.76M |
| 3 |
STMP
Stamps.com, Inc.
STMP
|
+$6.98M |
| 4 |
FIVE9
FIVN
|
+$5.97M |
| 5 |
WBT
Welbilt, Inc.
WBT
|
+$5.86M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$33.2M |
| 2 |
WORK
Slack Technologies, Inc.
WORK
|
+$16.9M |
| 3 |
MXIM
Maxim Integrated Products
MXIM
|
+$15.1M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$12.3M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.08% |
| 2 | Industrials | 14.12% |
| 3 | Technology | 10.69% |
| 4 | Communication Services | 9.56% |
| 5 | Materials | 3.44% |
Similar funds
THCM
WG
FAL
AIA
DMC
KL
UOC
MFA
Athos Capital's Q3 2021 Portfolio in Review
As of Q3 2021, Athos Capital held 179 positions worth $413M, down 17% from $499M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Athos Capital withdrew a net $84M in Q3 2021, closing 38 positions and reducing 5 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $33.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 22% a quarter earlier, followed by Industrials and Technology.
Against the trend, Athos Capital opened a new position in 51job Inc worth $20.2M.
- Athos Capital's largest Q3 2021 buy was 51job Inc: 290,511 shares worth $20.2M.
- Athos Capital added most to Welbilt, Inc. in Q3 2021, an estimated $5.86M increase.
- Athos Capital's biggest Q3 2021 reduction was Xilinx Inc, cutting an estimated $12.3M.
- Athos Capital fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $33.2M.
- Athos Capital's ten largest holdings make up 38% of its $413M portfolio in Q3 2021.
- Athos Capital opened 18 new positions and closed 38 in Q3 2021.
- Athos Capital's portfolio value fell 17% quarter-over-quarter to $413M.
Based on Athos Capital's 13F filing for Q3 2021, filed 12 Nov 2021.